What are the major opportunities in the Neuromodulation market? What are the strategies for the Neuromodulation market?

For detailed insights on the major opportunities and strategies in the Neuromodulation market, Read More

How does the Neuromodulation market relate to the overall economy and other similar markets?

For detailed insights on Neuromodulation's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Neuromodulation market growth? SWOT analysis of the Neuromodulation market.

For detailed insights on the key dynamics influencing the Neuromodulation market growth and SWOT analysis of the Neuromodulation industry, Read More

Neuromodulation Market Report Infographic Image

Item added to cart!

Published : January 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Neuromodulation Market Report 2026

Name: Neuromodulation Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Technology (Internal Neuromodulation, External Neuromodulation (Non-invasive)), By Biomaterial (Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial), By Application (Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications), By End-User (Hospitals, Clinics, Home Healthcare) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Neuromodulation Market Overview

• Neuromodulation market size has reached to $7.62 billion in 2025

• Expected to grow to $12.88 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%

• Growth Driver: Surge In Healthcare Expenditure Driving The Growth Of The Market Through Increased Research And Adoption Of Advanced Therapies

• Market Trend: Advancements In Implantable Pulse Generator (IPG) Technology Enable More Personalized And Efficient Neuromodulation Therapies

• North America was the largest region in 2025.

What Is Covered Under Neuromodulation Market?

Neuromodulation is the modification of nerve activity (or modulation) by delivering electrical or pharmacological substances directly to a specific location. It is a reversible procedure performed to relieve pain.

The main technologies involved in neuromodulation are internal neuromodulation and external neuromodulation (non-invasive). Internal neuromodulation involves implanting an electrode near a target nerve and delivering a low-voltage electric current through it. The biomaterials include polymeric biomaterial, metallic biomaterial, and ceramic biomaterial that are used for treating chronic pain, urinary and fecal incontinence, migraine, failed back syndrome, Parkinson’s disease, epilepsy, tremor, depression, and others by various end-users including hospitals, clinics, and home healthcare.

What Is The Neuromodulation Market Size and Share 2026?

The neuromodulation market size has grown rapidly in recent years. It will grow from $7.62 billion in 2025 to $8.45 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to rising prevalence of chronic pain conditions, growing incidence of neurological disorders, increased acceptance of minimally invasive therapies, expansion of specialized pain management centers, availability of advanced implantable devices.

What Is The Neuromodulation Market Growth Forecast?

The neuromodulation market size is expected to see rapid growth in the next few years. It will grow to $12.88 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing adoption of ai-assisted neuromodulation systems, rising demand for home-based neuromodulation therapies, expansion of indications in psychiatric and neurological disorders, growing focus on patient-specific stimulation protocols, continuous technological advancements in biomaterials and device miniaturization. Major trends in the forecast period include increasing adoption of implantable neuromodulation devices, rising use of non-invasive neuromodulation therapies, growing integration of smart and programmable stimulators, expansion of neuromodulation applications beyond pain, enhanced focus on personalized neurotherapy.

Book your 30 minutes free consultation with our research experts

Global Neuromodulation Market Segmentation

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)

2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial

3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications

4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems

2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

What Is The Driver Of The Neuromodulation Market?

Rising healthcare expenditures are expected to propel the growth of the neuromodulation market going forward. Healthcare expenditure refers to the total amount of money spent on health care and related activities, including the provision of health services, private and public health insurance, health research, and public health activities. Growing expenditures contribute to the development and adoption of new therapies and diagnostic methods for neurological disorders, and increased funding allows for more research into new neuromodulation technologies, improving their efficacy, safety, and targeting capabilities. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms in 2023, an increase of 0.9% growth compared to 2022. Therefore, rising healthcare expenditure is driving the growth of the neuromodulation industry.

Key Players In The Global Neuromodulation Market

Major companies operating in the neuromodulation market are Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuros Medical Inc., Koninklijke Philips N.V., Omron Corporation

Global Neuromodulation Market Trends and Insights

Major companies operating in the neuromodulation market are focusing on developing next-generation devices, such as advanced implantable pulse generators (IPGs), to improve therapeutic precision, enhance patient comfort, and maintain a competitive edge. An IPG is a compact, battery-powered device implanted under the skin, typically in the chest or abdomen, that delivers targeted electrical stimulation to manage neurological disorders. These innovations aim to provide greater customization, improved battery performance, and streamlined implantation procedures. For instance, in July 2023, Boston Scientific Corporation, a US-based biotechnology and biomedical engineering firm, received FDA approval for its Vercise Neural Navigator 5 software with STIMVIEW XT technology, designed for use with the fourth-generation Vercise Genus Deep Brain Stimulation (DBS) System. The platform includes both rechargeable and non-rechargeable IPGs and supports five MR-Conditional implantable pulse generators (IPGs), offering the most therapy options to personalize DBS therapy for individuals with Parkinson’s disease or essential tremor.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Neuromodulation Market?

In December 2024, electroCore Inc., a US-based bioelectronic medicine company, acquired NeuroMetrix Inc. for an undisclosed amount. Through this acquisition, electroCore aims to enhance its wearable neuromodulation capabilities for chronic pain by integrating NeuroMetrix’s Quell platform and expanding its portfolio of non-invasive bioelectronic therapies. NeuroMetrix Inc. is a US-based medical device company that develops wearable neuromodulation solutions targeting chronic pain management.

Regional Outlook

North America was the largest region in the neuromodulation market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Neuromodulation Market?

The neuromodulation market includes revenues earned by entities through sacral nerve stimulation for pelvic disorders and incontinence, deep brain stimulation (DBS) treatment for Parkinson's disease, and spinal cord stimulation for ischemic disorders (angina, peripheral vascular disease). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neuromodulation Market Report 2026?

The neuromodulation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neuromodulation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Neuromodulation Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$8.45 billion
Revenue Forecast In 2035	$12.88 billion
Growth Rate	CAGR of 10.9% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Technology, Biomaterial, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuros Medical Inc., Koninklijke Philips N.V., Omron Corporation
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Neuromodulation Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Neuromodulation Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Neuromodulation Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Neuromodulation Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence And Autonomous Intelligence

4.1.2 Biotechnology, Genomics And Precision Medicine

4.1.3 Industry 4.0 And Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data And Cybersecurity

4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Implantable Neuromodulation Devices

4.2.2 Rising Use Of Non-Invasive Neuromodulation Therapies

4.2.3 Growing Integration Of Smart And Programmable Stimulators

4.2.4 Expansion Of Neuromodulation Applications Beyond Pain

4.2.5 Enhanced Focus On Personalized Neurotherapy

5. Neuromodulation Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Pain Management Centers

5.4 Neurology Clinics

5.5 Home Healthcare Providers

6. Neuromodulation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neuromodulation Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Neuromodulation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Neuromodulation Market Size, Comparisons And Growth Rate Analysis

7.3. Global Neuromodulation Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Neuromodulation Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neuromodulation Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neuromodulation Market Segmentation

9.1. Global Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Internal Neuromodulation, External Neuromodulation (Non-invasive)

9.2. Global Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial

9.3. Global Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression

9.4. Global Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Home Healthcare, Other Applications

9.5. Global Neuromodulation Market, Sub-Segmentation Of Internal Neuromodulation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Implantable Devices, Intrathecal Drug Delivery Systems

9.6. Global Neuromodulation Market, Sub-Segmentation Of External Neuromodulation (Non-invasive), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

10. Neuromodulation Market Regional And Country Analysis

10.1. Global Neuromodulation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Neuromodulation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neuromodulation Market

11.1. Asia-Pacific Neuromodulation Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neuromodulation Market

12.1. China Neuromodulation Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neuromodulation Market

13.1. India Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neuromodulation Market

14.1. Japan Neuromodulation Market Overview

14.2. Japan Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neuromodulation Market

15.1. Australia Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neuromodulation Market

16.1. Indonesia Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neuromodulation Market

17.1. South Korea Neuromodulation Market Overview

17.2. South Korea Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neuromodulation Market

18.1. Taiwan Neuromodulation Market Overview

18.2. Taiwan Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neuromodulation Market

19.1. South East Asia Neuromodulation Market Overview

19.2. South East Asia Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neuromodulation Market

20.1. Western Europe Neuromodulation Market Overview

20.2. Western Europe Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neuromodulation Market

21.1. UK Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neuromodulation Market

22.1. Germany Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neuromodulation Market

23.1. France Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neuromodulation Market

24.1. Italy Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neuromodulation Market

25.1. Spain Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neuromodulation Market

26.1. Eastern Europe Neuromodulation Market Overview

26.2. Eastern Europe Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neuromodulation Market

27.1. Russia Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neuromodulation Market

28.1. North America Neuromodulation Market Overview

28.2. North America Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neuromodulation Market

29.1. USA Neuromodulation Market Overview

29.2. USA Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neuromodulation Market

30.1. Canada Neuromodulation Market Overview

30.2. Canada Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neuromodulation Market

31.1. South America Neuromodulation Market Overview

31.2. South America Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neuromodulation Market

32.1. Brazil Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neuromodulation Market

33.1. Middle East Neuromodulation Market Overview

33.2. Middle East Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neuromodulation Market

34.1. Africa Neuromodulation Market Overview

34.2. Africa Neuromodulation Market, Segmentation By Technology, Segmentation By Biomaterial, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neuromodulation Market Regulatory and Investment Landscape

36. Neuromodulation Market Competitive Landscape And Company Profiles

36.1. Neuromodulation Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Neuromodulation Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Neuromodulation Market Company Profiles

36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Soterix Medical Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Synapse Biomedical Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Neuromodulation Market Other Major And Innovative Companies

Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc.

38. Global Neuromodulation Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neuromodulation Market

40. Neuromodulation Market High Potential Countries, Segments and Strategies

40.1 Neuromodulation Market In 2030 - Countries Offering Most New Opportunities

40.2 Neuromodulation Market In 2030 - Segments Offering Most New Opportunities

40.3 Neuromodulation Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Neuromodulation Market, Overview Of Key Products - Product Examples

Table 2: Global Neuromodulation Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Neuromodulation Market, Supply Chain Analysis

Table 4: Global Neuromodulation Market, Major Raw Material Providers

Table 5: Global Neuromodulation Market, Major Resource Providers

Table 6: Global Neuromodulation Market, Major Manufacturers (Suppliers)

Table 7: Global Neuromodulation Market, Major Distributors And Channel Partners

Table 8: Global Neuromodulation Market, Key Technologies & Future Trends

Table 9: Global Neuromodulation Market, Major Trends

Table 10: Global Neuromodulation Market, Major End Users

Table 11: Global Neuromodulation Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Neuromodulation Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Neuromodulation Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Neuromodulation Market - TAM, US$ Billion, 2025

Table 15: Global Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Neuromodulation Market, Sub-Segmentation Of Internal Neuromodulation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Neuromodulation Market, Sub-Segmentation Of External Neuromodulation (Non-invasive), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Neuromodulation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Neuromodulation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Global Neuromodulation Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 96: Global Neuromodulation Market - Company Scoring Matrix

Table 97: Abbott Laboratories Financial Performance

Table 98: Soterix Medical Inc. Financial Performance

Table 99: Boston Scientific Corporation Financial Performance

Table 100: Medtronic plc Financial Performance

Table 101: Synapse Biomedical Inc. Financial Performance

Table 102: Global Neuromodulation Market, Competitive Benchmarking (In USD Billions)

Table 103: Global Neuromodulation Market, Competitive Dashboard

Table 104: Global Neuromodulation Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 105: Global, Neuromodulation Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Table 106: Global, Neuromodulation Market Size Gain ($ Billion), Segmentation By Biomaterial, 2025 – 2030

Table 107: Global, Neuromodulation Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

List Of Figures

Figure 1: Global Neuromodulation Market, Overview Of Key Products - Product Examples

Figure 2: Global Neuromodulation Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Neuromodulation Market, Supply Chain Analysis

Figure 4: Global Neuromodulation Market, Major Raw Material Providers

Figure 5: Global Neuromodulation Market, Major Resource Providers

Figure 6: Global Neuromodulation Market, Major Manufacturers (Suppliers)

Figure 7: Global Neuromodulation Market, Major Distributors And Channel Partners

Figure 8: Global Neuromodulation Market, Key Technologies & Future Trends

Figure 9: Global Neuromodulation Market, Major Trends

Figure 10: Global Neuromodulation Market, Major End Users

Figure 11: Global Neuromodulation Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Neuromodulation Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Neuromodulation Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Neuromodulation Market - TAM, US$ Billion, 2025

Figure 15: Global Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Neuromodulation Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Neuromodulation Market, Sub-Segmentation Of Internal Neuromodulation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Neuromodulation Market, Sub-Segmentation Of External Neuromodulation (Non-invasive), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Neuromodulation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Neuromodulation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Neuromodulation Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Neuromodulation Market, Segmentation By Biomaterial, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Neuromodulation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Global Neuromodulation Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 96: Global Neuromodulation Market - Company Scoring Matrix

Figure 97: Abbott Laboratories Financial Performance

Figure 98: Soterix Medical Inc. Financial Performance

Figure 99: Boston Scientific Corporation Financial Performance

Figure 100: Medtronic plc Financial Performance

Figure 101: Synapse Biomedical Inc. Financial Performance

Figure 102: Global Neuromodulation Market, Competitive Benchmarking (In USD Billions)

Figure 103: Global Neuromodulation Market, Competitive Dashboard

Figure 104: Global Neuromodulation Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 105: Global, Neuromodulation Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Figure 106: Global, Neuromodulation Market Size Gain ($ Billion), Segmentation By Biomaterial, 2025 – 2030

Figure 107: Global, Neuromodulation Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030

In-Depth Aerosol Drug Delivery Devices Market Report: Business Trends, Growth Factors, and Forecast to 2029

2025 Analysis: Opportunities and Risks in the Evolving Ambulance Stretchers Market

Industry Forecast: Antimicrobial Resistance Diagnostics Market to Generate $5.82 Billion Revenue by 2029

Emerging Trends and Growth Drivers in the Artificial Intelligence (AI) In Endoscopy Market Through 2029

The global medical gloves market report offers strategic insights and market intelligence through 2025.

Explore future investment planning strategies in the global medical needle-free injection market through 2025.

Strategic growth analysis and competitive advantage in the global topoisomerase I inhibitors market.

Explore business opportunities, growth strategies, and trends in the total ankle replacement market through 2034.

End Stage Renal Disease (ESRD) Drug Market Report 2026 - Global Outlook – By Product Type (Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders, Other Products), By Indication (End Stage ...

Neurostimulation Devices Market Report 2026 - Global Outlook – By Product (Implantable Devices, External Devices), By Application (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, ...

Fluid Dispensing Systems Market Report 2026 - Global Outlook – By Product (Flux, Lubricant, Solder Paste, Adhesives And Sealants, Conformal Coatings, Other Products), By Machine Type (Manual, Semi-Automatic, Automatic), ...

Agricultural Biologics Market Report 2026 - Global Outlook – By Type (Biopesticides, Biofertilizers, Biostimulants), By Source (Microbials, Macrobials, Biochemicals, Other Sources), By Mode of Application (Foliar Spray, ...

Frequently Asked Questions

What is the projected market size of the Neuromodulation Market Report 2026 market by 2030?

The Neuromodulation Market Report 2026 market was valued at $7.62 billion in 2025, increased to $8.45 billion in 2026, and is projected to reach $12.88 billion by 2030. request a sample here

What is the expected CAGR for the Neuromodulation Market Report 2026 market during the forecast period 2025 - 2030?

The expected CAGR for the Neuromodulation Market Report 2026 market during the forecast period 2025–2030 is 11.1%. request a sample here

What are the key factors driving the Neuromodulation Market Report 2026 market?

Major growth driver of the market includes: Surge In Healthcare Expenditure Driving The Growth Of The Market Through Increased Research And Adoption Of Advanced Therapies in the Neuromodulation Market Report 2026 market. For further insights on this market, request a sample here

Which end-use segment are covered in the Neuromodulation Market Report 2026 market report?

The neuromodulation market covered in this report is segmented –
1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)
2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial
3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications
4) By End-User: Hospitals, Clinics, Home Healthcare Subsegments:
1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems
2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS) request a sample here

What is the anticipated growth trend for the Neuromodulation Market Report 2026 market?

Major trend in this market includes: Advancements In Implantable Pulse Generator (IPG) Technology Enable More Personalized And Efficient Neuromodulation Therapies For further insights on this market, request a sample here.

Who are the key players in the Neuromodulation Market Report 2026 market?

Major companies operating in the Neuromodulation Market Report 2026 market are Major companies operating in the neuromodulation market are Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, NeuroPace Inc., LivaNova PLC, NeuroSigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, Inspire Medical Systems Inc., Saluda Medical Pty Ltd, Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuros Medical Inc., Koninklijke Philips N.V., Omron Corporation request a sample here.

Which region has the most growth potential in the Neuromodulation Market Report 2026 market?

North America was the largest region in the neuromodulation market in 2025. The regions covered in the neuromodulation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.